Variability in the Use of Novel Diagnostic Technology in Children With Suspected Encephalitis and in the Management of Emerging Encephalitides by Pediatric Infectious Disease Providers

Walter Dehority; Andrew B Janowski; Kevin Messacar; Philip M Polgreen; Susan E Beekmann

doi:10.1093/jpids/piaa149

Variability in the Use of Novel Diagnostic Technology in Children With Suspected Encephalitis and in the Management of Emerging Encephalitides by Pediatric Infectious Disease Providers

J Pediatric Infect Dis Soc. 2021 Apr 30;10(4):529-532. doi: 10.1093/jpids/piaa149.

Authors

Walter Dehority¹, Andrew B Janowski², Kevin Messacar^{3

4}, Philip M Polgreen⁵, Susan E Beekmann⁵

Affiliations

¹ Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
² Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
³ Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.
⁴ Department of Pediatrics, Children's Hospital Colorado, Aurora, Colorado, USA.
⁵ Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.

Abstract

We surveyed pediatric infectious disease physicians through the Infectious Disease Society of America's Emerging Infections Network regarding the diagnosis and management of encephalitis. We identified practice variations, particularly with the use of new diagnostic modalities and management of autoimmune encephalitides. These findings may inform the creation of updated management guidelines.

Keywords: encephalitis; metagenomic next generation sequencing; multiplex polymerase chain reaction; pediatric; survey.

© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

MeSH terms

Child
Communicable Diseases*
Encephalitis* / diagnosis
Hashimoto Disease*
Humans
Technology

Abstract

MeSH terms

Grants and funding